Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Palliative treatment of chronic myeloid leukemia Age: Adult |
Dose: Oral – 60 mcg/kg Frequency: daily |
|
Indication: Palliative treatment of chronic myeloid leukemia Age: Adult Condition: Maintenance |
Dose: Oral – 0.5-2 mg Frequency: daily Note: Maximum: 4 mg daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Conditioning treatment prior to conventional haematopoietic progenitor cell transplantation Age: 0 to 17 years |
Dose: Intravenous infusion – 1.0 mg/kg Frequency: every 6 hours Duration: 4 consecutive days Note: total 16 doses |
|
Indication: Conditioning treatment prior to conventional haematopoietic progenitor cell transplantation Age: 0 to 17 years |
Dose: Intravenous infusion – 1.2 mg/kg Frequency: every 6 hours Duration: 4 consecutive days Note: total 16 doses |
Administration
- Can be taken with or without food
- Take with cool liquid
Side Effect
- GI symptoms
- anorexia
- weight loss
- weakness
- hyperpigmentation
- amenorrhoea
- cataracts
- cough or hoarseness
- impaired fertility and gonadal function
- dry skin
- liver damage
- gynaecomastia
- Bone marrow depression manifesting as thrombocytopaenia
- leucopaenia
- anaemia
- Interstitial pulmonary fibrosis (known as "busulfan lung" on prolonged treatment)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Cyclophosphamide, itraconazole
|
Decreased clearance
|
|
Phenytoin
|
Increased clearance
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Tab: Store below 25°C.
Inj concentrate: Store between 2-8°C.
Do not freeze.
Inj concentrate: Store between 2-8°C.
Do not freeze.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.